Case number 1:22-cv-00165
Bayer Pharma AG et al v. Micro Labs Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 13, 2022 | 15 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (Attachments: # (1) Order)(nms) |
| Jul 13, 2022 | 15 | Order (2) |
| Jul 12, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 91 in Lead Civil Action 21-314-RGA-JLH. (nms) |
| Apr 5, 2022 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Micro Labs' Rule 26(a)(1) Initial Disclosures; and (2) Micro Labs' Paragraph 3 Disclosures filed by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth) |
| Mar 22, 2022 | 13 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Civil Action No. 22-165-RGA is consolidated for all purposes, including trial, with Civil Action 21-314-RGA, and all papers shall be filed in Civil Action No. 21-314-RGA. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 7/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A 2 day Bench Trial is set to start 5/30/2023, at 8:30 AM in Courtroom 6A. Signed by Judge Richard G. Andrews on 3/22/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-00165-RGA(nms) |
| Mar 21, 2022 | 12 | Main Document (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Fahnestock, Derek) Modified on 3/21/2022 (nms). |
| Mar 21, 2022 | 12 | Letter to The Honorable Richard G. Andrews (1) |
| Mar 8, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Answer filed on 3/7/2022, at D.I. 10 and the Disclosure Statement filed that same day at D.I. 11 have been removed from the docket. This case relates to a pending MDL and therefore all pleading need inclusion of the MDL matter in the caption. Defendant is to refile (both in this case and the MDL) the answer and disclosure statement correcting this deficiency. (nms) |
| Mar 8, 2022 | 10 | Answer to Complaint (28) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Micro Labs USA Inc., Micro Labs Ltd..(Dorsney, Kenneth) |
| Mar 8, 2022 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Micro Labs Ltd. for Micro Labs USA, Inc. filed by Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth) |
| Feb 15, 2022 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. Micro Labs Ltd. served on 2/14/2022, answer due 3/7/2022. (Fahnestock, Derek) |
| Feb 15, 2022 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. Micro Labs USA Inc. served on 2/14/2022, answer due 3/7/2022. (Fahnestock, Derek) |
| Feb 14, 2022 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Micro Labs Ltd. and Micro Labs USA Inc. (nmg) |
| Feb 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Feb 7, 2022 | 7 | Summons Issued (4) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Micro Labs Ltd. on 2/7/2022; Micro Labs USA Inc. on 2/7/2022. (nmg) |
| Feb 4, 2022 | 1 | Main Document (11) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Micro Labs Ltd., Micro Labs USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3796508.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Feb 4, 2022 | 1 | Exhibit A (27) |
| Feb 4, 2022 | 1 | Civil Cover Sheet (1) |
| Feb 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Feb 4, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: on or about 12/30/2021. Date of Expiration of Patent: See attached. (nmg) |
| Feb 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (nmg) |
| Feb 4, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG. (nmg) |
| Feb 4, 2022 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (nmg) |
| Feb 4, 2022 | 1 | Complaint* (1) |
